Scilla, K. A., Bentzen, S. M., Lam, V. K., Mohindra, P., Nichols, E. M., Vyfhuis, M. A., . . . Feliciano, J. L. (2017). Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy. Oncologist.
Chicago Stili AlıntıScilla, Katherine A., et al. "Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients With Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated With Combined Modality Therapy." Oncologist 2017.
MLA AlıntıScilla, Katherine A., et al. "Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients With Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated With Combined Modality Therapy." Oncologist 2017.